Home Data Calendar Blog

TRVN

Tables

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Common Stock Value		0.00	0.02	0.02	0.01
Weighted Average Number Of Diluted Shares Outstanding		0.85	21.32	NA	13.96
Weighted Average Number Of Shares Outstanding Basic		0.85	21.32	NA	13.96
Earnings Per Share Basic		-5.79	-0.23	-1.13	-0.57
Earnings Per Share Diluted		-5.79	-0.23	-1.13	-0.57

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Cost Of Revenue		0.11	0.10	1.28	0.17
Costs And Expenses		5.86	6.83	10.06	9.01
Research And Development Expense		1.87	3.13	4.17	4.26
General And Administrative Expense		3.88	3.60	4.61	4.57
Operating Income Loss		-5.58	-6.50	-10.15	-8.83
Interest Expense		0.00	0.52	1.87	0.21
Allocated Share Based Compensation Expense		0.56	0.59	0.73	0.69
Profit Loss		-4.94	-4.89	-16.53	-7.93
Net Income Loss		-4.94	-4.89	-16.49	-7.93
Net Income Loss Available To Common Stockholders Basic		-4.94	-4.89	-16.53	-7.93

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Assets		19.19	22.94	40.60	45.13
Liabilities		42.50	41.90	48.26	41.58
Liabilities And Stockholders Equity		19.19	22.94	40.60	45.13
Stockholders Equity		-23.31	-18.96	-7.66	3.55

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Assets Current		14.73	18.03	35.20	39.48
Cash And Cash Equivalents At Carrying Value		13.46	16.37	32.98	34.95
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		14.08	16.91	33.52	35.49
Inventory Finished Goods		1.16	0.90	0.90	0.90
Prepaid Expense And Other Assets Current		0.99	1.66	2.23	3.45

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Property Plant And Equipment Net		0.92	1.02	1.20	1.26

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Liabilities Current		6.09	5.21	7.55	6.16
Long Term Debt Current		0.90	NA	NA	NA
Accounts Payable Current		0.92	1.13	2.30	1.54

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Long Term Debt Noncurrent		31.97	31.53	30.81	29.64
Operating Lease Liability Noncurrent		3.59	3.87	4.42	4.68

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Stockholders Equity		-23.31	-18.96	-7.66	3.55
Common Stock Value		0.00	0.02	0.02	0.01
Additional Paid In Capital Common Stock		582.26	581.65	580.39	575.07
Retained Earnings Accumulated Deficit		-605.57	-600.63	-588.06	-571.53

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Net Cash Provided By Used In Operating Activities		-4.50	-7.18	-5.99	-8.93
Net Cash Provided By Used In Financing Activities		1.68	-0.00	4.03	15.78

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Net Cash Provided By Used In Operating Activities		-4.50	-7.18	-5.99	-8.93
Net Income Loss		-4.94	-4.89	-16.49	-7.93
Profit Loss		-4.94	-4.89	-16.53	-7.93
Depreciation Depletion And Amortization		0.10	0.09	0.09	0.08
Share Based Compensation		0.56	0.59	0.73	0.69

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Net Cash Provided By Used In Financing Activities		1.68	-0.00	4.03	15.78

		2024-09-30	2024-06-30	2023-12-31	2023-09-30
Jiangsu Nhwa Pharmaceutical Co Ltd, Royalty		0.30	0.31	0.00	0.18
License And Royalty		0.30	0.31	0.00	0.18
Royalty		0.30	0.31	0.00	0.18

Plots across concepts

Line plots across dimensions of each concept